Art

J-GLOBAL ID：201902210781019775   Reference number：19S1775153

A case of high-grade neuroendocrine carcinoma that improved with bevacizumab plus modified FOLFOX6 as the fourth-line chemotherapy

Author (9)： Takeuchi, Satoshi (Department of Medical Oncology, Hokkaido University Graduate School of Medicine) ,  Honma, Rio (Department of Medical Oncology, Hokkaido University Graduate School of Medicine) ,  Taguchi, Jun (Department of Medical Oncology, Hokkaido University Graduate School of Medicine) ,  Amano, Toraji (Department of Medical Oncology, Hokkaido University Graduate School of Medicine) ,  Shimizu, Yasushi (Department of Medical Oncology, Hokkaido University Graduate School of Medicine) ,  Kinoshita, Ichiro (Department of Medical Oncology, Hokkaido University Graduate School of Medicine) ,  Dosaka-Akita, Hirotoshi (Department of Medical Oncology, Hokkaido University Graduate School of Medicine) ,  Kubota, Kanako (Department of Surgical Pathology, Hokkaido University Hospital) ,  Matsuno, Yoshihiro (Department of Surgical Pathology, Hokkaido University Hospital)
Material： Case Reports in Oncology
Volume： 4  Issue： 2  Page： 260-266  Publication year： 2011 
JST Material Number： SCOPUS  ISSN： 1662-6575 
Country of issue： Switzerland (CHE)  Language： English (EN)

Terms in the title (3)： CASE ,  BEVACIZUMAB ,  FOLFOX6